Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...ld standard in tracking and reporting global funding for neglected disease R&D. This year’s report, the sixteenth overall, focuses on investments made in participants’ 2022 financial year (‘FY2022’) and, for the first time, adds comprehensive coverage of the product pipeline in each disease area.
more
MSD Manual Ausgabe für Medizinische Kreise. In verschiedenen Sprachen aufrufbar:
English, Francais, Portuguese, Espagnol, Russian, Chinese, etc.
In this ISNTD Connect and GSA collaborative webinar scientists discuss schistosomiasis control, elimination and innovation in the Philippines.
Infectious Diseases of Poverty (2022) 11:111; With some 134,073,166 people living in endemic communities at risk of infection, Nigeria is the most endemic country in Africa and requires preventive chemotherapy (PC) for a total of 26.3 million persons. The National Schistosomiasis Elimination Program...me (NSCHEP), with the support of international partners, has been implementing PC in Nigeria since 2009 and most recently will need to revise its current strategy (Additional file 1). For example, the new World Health Organization (WHO) guideline has six key recommendations that will dramatically change the implementation of schistosomiasis elimination in endemic countries [3]. However, its impact and programmatic implications will vary from country to country, hence the need for a country-specific analysis. This article discusses these recommendations with specific reference to the challenges and opportunities in Nigeria. We summarise the key pointers in Additional file 1: Box 1 against the six recommendations of the WHO 2022 guideline.
more
The Global Schistosomiasis Alliance
The Global Schistosomiasis Alliance (GSA) is an all-inclusive coalition to mobilise the growing momentum to control and eliminate schistosomiasis. It is constituted as a diverse but representative partnership of public health programmes, academic and research ...institutions, international development agencies and foundations, non-governmental organizations, private sector companies and advocacy and resource-mobilisations partners. Our alliance is not limited to partner organizations but also includes individuals, research groups and different networks, collaborating together as a community to control and eliminate schistosomiasis.
more
Praziquantel is effective at treating infections with all major Schistosoma species.
The American Jornal of Tropical Medicine and Hygiene, vol. 105, no.6, pp.1772-1781.
Schistosomiasis, which is the second most important parasitic infection after malaria in terms of its socioeconomic impact, is responsible for the loss of an estimated 4.5 million disability-adjusted life years (DA...LYs) worldwide. Schistosomiasis, including both intestinal and urinary forms of the disease, occurs in 78 countries across the globe. An estimated 240 million people are infected, with more than 779 million living at risk globally. The majority of those infected and those at risk for infection live in low-income countries, and approximately 80% of the morbidity occurs in impoverished communities and households in sub-Saharan Africa. Within Uganda, 91 of the 134 districts are endemic for intestinal schistosomiasis caused by Schistosoma mansoni, and the eastern region, especially along Lake Victoria, has one of the highest S. mansoni burdens worldwide. Schistosoma haematobium is only endemic in the five districts of the Lango region in northern Uganda.
more
Schistosomiasis, also known as Bilharzia, is an infection caused by a parasitic worm that lives in fresh water in subtropical and tropical regions. Schistosomiasis is second only to malaria as the most devastating parasitic disease. The parasites that cause schistosomiasis live in certain types of f...reshwater snails. The infectious form, known as cercariae, emerge from the snail and then contaminate the water. People become infected when their skin comes into contact with the contaminated freshwater. Most human infections are caused by Schistosoma mansoni, Schistosoma haematobium, or Schistosoma japonicum.
more
داء البلهارسيات هو مرض طفيلي حاد ومزمن تسبّبه الديدان المثقوبة الدموية (المثقوبات) من جنس البلهارسية. وتشير التقديرات إلى أن 251.4 مليون شخص على الأقل كانوا بحاجة إلى ...لعلاج الوقائي من داء البلهارسيات في عام 2021. ومن شأن العلاج الوقائي، الذي ينبغي تكراره على مدى عدة سنوات، أن يحد من المراضة ويمنعها. وقد أُبلغ عن سريان المرض في 78 بلداً. ومع ذلك، فإن العلاج الكيميائي الوقائي لداء البلهارسيات الذي يُستهدف فيه الأشخاص والمجتمعات المحلية بالعلاج على نطاق واسع، لا يلزم إلا في 51 بلداً موطوناً يشهد مستويات سريان المرض المتوسطة أو العالية.
more
PLoS Negl Trop Dis 10(7): e0004794. doi:10.1371/journal.pntd.0004794
Schistosome snail resource (SSR) is Wellcome Trust funded, open access biomedical resource that aims to generate and make freely available live schistosome life-cycle stages, snail intermediate hosts and related material for schistosomiasis research.
Schistosomiasis is a tropical disease caused by a group of parasitic worms. It has an interesting life-cycle involving freshwater snails and can cause short term and long term disease. Schistosomiasis is classified as a neglected tropical disease and affects some of the poorest countries in the worl...d.
This video takes a look at the parasites, the disease that it causes and control methods.
more
Brazil Standard Operation Procedures* for the identification of Biomphalaria snails, infectivity and infection status of Biomphalaria snails.
Schistosomiases are acute or chronic visceral parasitic diseases due to 5 species of trematodes (schistosomes). The three main species infecting humans are Schistosoma haematobium, Schistosoma mansoni and Schistosoma japonicum. Schistosoma mekongi and Schistosoma intercalatum have a more limited dis...tribution.
more
Schistosoma haematobium] [Schistosoma intercalatum] [Schistosoma japonicum] [Schistosoma mansoni] [Schistosoma mekongi]
The consortium is an international public-private partnership that aims to reduce the global disease burden of schistosomiasis by addressing the medical needs of infected children between the ages of 3 months and 6 years. By doing so, we hope to contribute to the ongoing efforts to eliminate schisto...somiasis and improve child health.
more
Global Health Observatory (GHO) interactive graph
SIXTY-FIFTH WORLD HEALTH ASSEMBLY WHA 65.21